What first‑line antibiotic and dosing is recommended for a 12‑year‑old child with bacterial pneumonia, and what alternative should be used if the child has a documented penicillin allergy?

First-Line Antibiotic for Bacterial Pneumonia in a 12-Year-Old Child

Amoxicillin 90 mg/kg/day divided into two doses (maximum 4 g/day) is the definitive first-line antibiotic for a 12-year-old child with bacterial pneumonia, providing optimal coverage against Streptococcus pneumoniae, the most common bacterial pathogen. 1

Standard First-Line Regimen

• High-dose amoxicillin at 90 mg/kg/day (not the lower 45 mg/kg/day dose) is essential to overcome penicillin-resistant S. pneumoniae strains with MICs up to 2–4 mg/L. 2, 3

• This regimen should be administered twice daily for 7–10 days, with most guidelines favoring the full 10-day course for pneumonia. 2, 3

• The maximum total daily dose is 4,000 mg (4 g) per day, regardless of the child's weight. 2

When to Add Atypical Coverage

• Add azithromycin (10 mg/kg on day 1, then 5 mg/kg/day on days 2–5, maximum 500 mg day 1 and 250 mg/day thereafter) if atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae) are suspected based on:

  • Persistent dry cough without high fever 3
  • Interstitial infiltrates on chest radiograph 3
  • Gradual onset over several days 1

• School-aged children and adolescents have higher rates of atypical pneumonia than younger children, making dual therapy more commonly indicated in this age group. 1

Alternative for Documented Penicillin Allergy

Non-Anaphylactic Penicillin Allergy

• Oral cephalosporins (cefpodoxime, cefprozil, or cefuroxime) are appropriate alternatives for non-severe allergic reactions, as the cross-reactivity risk is only 1–3%. 2, 4

• These agents provide adequate coverage for S. pneumoniae and Haemophilus influenzae when administered under medical supervision. 4

Severe (Type I/Anaphylactic) Penicillin Allergy

• Azithromycin is the preferred alternative for severe penicillin allergy:

  • Dosing: 10 mg/kg on day 1 (maximum 500 mg), then 5 mg/kg once daily on days 2–5 (maximum 250 mg/day) 4
  • Provides coverage for both typical bacterial pathogens and atypical organisms 4

• Levofloxacin is an alternative fluoroquinolone option for severe allergy:

  • Children 5–16 years: 8–10 mg/kg once daily (maximum 750 mg/day) 3, 4
  • Reserved for situations where macrolides are unsuitable or have failed 3

• Critical caveat: Macrolide monotherapy should be used cautiously in severe pneumococcal disease due to potential for secondary sites of infection, including meningitis. 4

Clinical Monitoring and Expected Response

• Children on appropriate therapy should demonstrate clinical improvement within 48–72 hours (reduced fever, improved respiratory effort, better oral intake). 2, 3

• If no improvement occurs within 48–72 hours, reassess for:

  • Resistant pathogens or atypical organisms requiring macrolide addition 3
  • Complications such as pleural effusion or necrotizing pneumonia 3
  • Need for hospitalization and parenteral therapy 3

When to Hospitalize and Use Parenteral Therapy

• Immediate hospitalization criteria include:

  • Oxygen saturation ≤ 92% on room air 3, 4
  • Respiratory rate > 50 breaths/min, severe retractions, or grunting 3
  • Inability to tolerate oral medication or signs of dehydration 3, 4
  • No clinical improvement after 48–72 hours of appropriate outpatient therapy 3

• Parenteral options for hospitalized children:

  • Ampicillin 150–200 mg/kg/day IV every 6 hours OR penicillin G 200,000–250,000 U/kg/day IV every 4–6 hours for fully immunized, low-risk patients 1, 3
  • Ceftriaxone 50–100 mg/kg/day IV every 12–24 hours OR cefotaxime 150 mg/kg/day IV every 8 hours for not fully immunized or high-risk patients 1, 3

Common Pitfalls to Avoid

• Underdosing amoxicillin (using 40–45 mg/kg/day instead of 90 mg/kg/day) is a dangerous and common error that results in inadequate pneumococcal coverage. 3

• Using macrolides as first-line monotherapy for presumed bacterial pneumonia is inappropriate, as they lack reliable activity against S. pneumoniae in many regions due to resistance. 3

• Failure to consider MRSA in children with severe pneumonia, necrotizing infiltrates, empyema, or recent influenza infection; these situations require addition of vancomycin (40–60 mg/kg/day IV every 6–8 hours) or clindamycin (40 mg/kg/day IV every 6 hours) to the β-lactam regimen. 3